Researcher.Life Logo

Journal of Global Oncology : Impact Factor & More

eISSN: 2378-9506
JournalOpen Access

Key Metrics

Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Global Oncology

Journal of Global Oncology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher American Society of Clinical Oncology
Language English
Article Processing ChargesUSD 2400
Publication Time20
Editorial Review ProcessBlind peer review
General Details
LanguageEnglish
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 20
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessBlind peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Journal of Global Oncology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Global Oncology

Germline Pathogenic Variants in Breast Cancer-Predisposing Genes Among Early-Onset Female and Male Breast Cancer in Ethiopia.
  • 1 May 2026
  • JCO global oncology
Prevalence and Factors Associated With Financial Toxicity Among Patients With GI Cancer in Pakistan.
  • 1 May 2026
  • JCO global oncology
Blind Spots in Oncology Guidelines: Evidence and Practice in India and Low- and Middle-Income Country Parallels.
  • 1 May 2026
  • JCO global oncology
Erratum: Evolution of Therapy in Pediatric ALL From Aminopterin to Chimeric Antigen Receptor T-Cell Therapy: Global Advances, Indian Adaptations, and Lessons for Low- and Middle-Income Countries.
  • 1 May 2026
  • JCO global oncology
Outcomes of Hypofractionated Radiotherapy in Patients With Geriatric Head and Neck Cancer: Role of Comprehensive Geriatric Assessment.
  • 1 May 2026
  • JCO global oncology
Improving Chimeric Antigen Receptor T Access in Latin America: Promises, Barriers, and a Call to Action.
  • 1 Apr 2026
  • JCO global oncology
Germline Pathogenic Variants in Breast Cancer-Predisposing Genes Among Early-Onset Female and Male Breast Cancer in Ethiopia.
  • 1 May 2026
  • JCO global oncology
Prevalence and Factors Associated With Financial Toxicity Among Patients With GI Cancer in Pakistan.
  • 1 May 2026
  • JCO global oncology
Blind Spots in Oncology Guidelines: Evidence and Practice in India and Low- and Middle-Income Country Parallels.
  • 1 May 2026
  • JCO global oncology
Erratum: Evolution of Therapy in Pediatric ALL From Aminopterin to Chimeric Antigen Receptor T-Cell Therapy: Global Advances, Indian Adaptations, and Lessons for Low- and Middle-Income Countries.
  • 1 May 2026
  • JCO global oncology
Outcomes of Hypofractionated Radiotherapy in Patients With Geriatric Head and Neck Cancer: Role of Comprehensive Geriatric Assessment.
  • 1 May 2026
  • JCO global oncology
Improving Chimeric Antigen Receptor T Access in Latin America: Promises, Barriers, and a Call to Action.
  • 1 Apr 2026
  • JCO global oncology

FAQs on Journal of Global Oncology